Halberd Corporation (HALB)
OTCMKTS · Delayed Price · Currency is USD
0.0024
-0.0001 (-2.04%)
Aug 1, 2025, 2:58 PM EDT

Halberd Company Description

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases.

It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer’s and Parkinson’s disease, cancer, blood-borne, and cerebrospinal fluid related diseases.

The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

Halberd Corporation
CountryUnited States
Founded2009
IndustryBiotechnology
SectorHealthcare
Employees3
CEOWilliam Hartman

Contact Details

Address:
PO Box 25
Jackson Center, Colorado 16133
United States
Phone814 786 8849
Websitehalberdcorporation.com

Stock Details

Ticker SymbolHALB
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearAugust - July
Reporting CurrencyUSD
ISIN NumberUS4053311092
SIC Code2834

Key Executives

NamePosition
William A. HartmanPresident, Chief Executive Officer and Chairman
John S. Borza AVS, MBA, PEChief Operating Officer and Director
Heidi H. CarlDirector and Accounting Director
Dr. Mitchell S. Felder M.D.Chief Technology Officer and Member of the Scientific Advisory Board
Dr. Patricio F. Reyes FAAN, M.D.Chief Mechanical Officer and Member of the Scientific Advisory Board